{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:44:39Z","timestamp":1792500279496,"version":"4.5.0"},"reference-count":206,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.metabol.2016.05.018","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T02:32:19Z","timestamp":1465266739000},"page":"1376-1390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":247,"title":["Role of metabolism in neurodegenerative disorders"],"prefix":"10.1016","volume":"65","author":[{"given":"Claudio","family":"Procaccini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Santopaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deriggio","family":"Faicchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Colamatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"de Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Galgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-0616","authenticated-orcid":false,"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.05.018_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","article-title":"Epidemiology of Parkinson's disease","volume":"255","author":"Alves","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12264-008-0105-7","article-title":"Alzheimer's disease: Epidemiology, genetics, and beyond","volume":"24","author":"Wang","year":"2008","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.metabol.2016.05.018_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0301-0082(02)00126-0","article-title":"Impact of aging on hippocampal function: Plasticity, network dynamics, and cognition","volume":"69","author":"Rosenzweig","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0020","series-title":"Obesity and Overweight: Fact Sheet No 311","author":"WHO","year":"2013"},{"key":"10.1016\/j.metabol.2016.05.018_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2009.07.008","article-title":"The effect of obesity on health outcomes","volume":"316","author":"Dixon","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.59.7.1051","article-title":"Midlife adiposity and the future risk of Parkinson's disease","volume":"59","author":"Abbott","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ijo.2009.104","article-title":"Overweight in midlife and risk of dementia: A 40-year follow-up study","volume":"33","author":"Hassing","year":"2009","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2016.05.018_bb0040","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0045","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182190d09","article-title":"Midlife overweight and obesity increase late-life dementia risk: A population-based twin study","volume":"76","author":"Xu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2377-5-23","article-title":"The effect of body mass index on global brain volume in middle-aged adults: A cross sectional study","volume":"5","author":"Ward","year":"2005","journal-title":"BMC Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0055","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neuroimage.2006.01.047","article-title":"Brain abnormalities in human obesity: A voxel-based morphometric study","volume":"31","author":"Pannacciulli","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.metabol.2016.05.018_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/156720507780362263","article-title":"Relation of obesity to cognitive function: Importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart study","volume":"4","author":"Wolf","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0070","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1074\/jbc.M609521200","article-title":"Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation","volume":"282","author":"Kuhla","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.201104133","article-title":"Single-channel Ca2+ imaging implicates A\u03b2 1\u201342 amyloid pores in Alzheimer's disease pathology","volume":"195","author":"Demuro","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","article-title":"Production of the Alzheimer amyloid beta protein by normal proteolytic processing","volume":"258","author":"Shoji","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.05.018_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1993.tb18213.x","article-title":"Aberrant proteolysis of the beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells","volume":"217","author":"Matsumoto","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0090","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","article-title":"Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein","volume":"88","author":"Cras","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.05.018_bb0095","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.metabol.2016.05.018_bb0100","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ajmg.a.32422","article-title":"Fear of health insurance loss among individuals at risk for Huntington disease","volume":"146A","author":"Oster","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.metabol.2016.05.018_bb0105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","article-title":"Obesity in middle age and future risk of dementia: A 27year longitudinal population based study","volume":"330","author":"Whitmer","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2016.05.018_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/156720512799015064","article-title":"Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders","volume":"9","author":"Cai","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0115","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0120","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0125","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: The Rotterdam study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease \u2013 is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2337\/db11-1186","article-title":"Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities","volume":"61","author":"Carvalho","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.05.018_bb0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-130005","article-title":"Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies","volume":"35","author":"Carvalho","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0150","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2016.05.018_bb0155","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1signaling in neurodegenerative disorders: Targets for disease modification?","volume":"118","author":"Bassil","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson's disease, insulin resistance and novel agents of neuroprotection","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2016.05.018_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","article-title":"The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: An overview of the LEAD 1-5 studies","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2016.05.018_bb0175","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide- 1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0165-6147(03)00160-3","article-title":"The glucagon-like peptides: A double-edged therapeutic sword?","volume":"24","author":"Perry","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2008.08.047","article-title":"Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide","volume":"444","author":"Qin","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.metabol.2016.05.018_bb0190","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0195","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease","volume":"19","author":"Li","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0200","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.1996.tb00912.x","article-title":"Weight change in Alzheimer's disease","volume":"44","author":"White","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.metabol.2016.05.018_bb0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1749-6632.2002.tb04293.x","article-title":"Leptin signaling, adiposity, and energy balance","volume":"967","author":"J\u00e9quier","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.125","article-title":"Neuroprotection by leptin in a rat model of permanent cerebral ischemia: Effects on STAT3 phosphorylation in discrete cells of the brain","volume":"2","author":"Amantea","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0220","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2016.05.018_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020286","article-title":"Adipocytokines and CD34 progenitor cells in Alzheimer's disease","volume":"6","author":"Bigalke","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2016.05.018_bb0230","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.04-2572com","article-title":"Obesity-related leptin regulates Alzheimer's a beta","volume":"18","author":"Fewlass","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2016.05.018_bb0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","article-title":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells","volume":"380","author":"Greco","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.05.018_bb0240","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease","volume":"19","author":"Greco","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: Evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0250","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2004-1979","article-title":"Effect of leptin replacement on brain structure in genetically leptin deficient adults","volume":"90","author":"Matochik","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.05.018_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2010-101263","article-title":"Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intra hippocampal amyloid-\u03b2-1\u201342 oligomer injected mice","volume":"23","author":"Moon","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/en.2006-0991","article-title":"Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen\u2013glucose deprivation","volume":"148","author":"Chung","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0265","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jne.12138","article-title":"Protective effect of leptin and ghrelin against toxicity induced by amyloid-\u03b2oligomers in a hypothalamic cell line","volume":"26","author":"Gomes","year":"2014","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2003.11.150","article-title":"Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin","volume":"313","author":"Carlini","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.05.018_bb0275","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.175r001","article-title":"Plasma ghrelin concentrations in elderly subjects: Comparison with anorexic and obese patients","volume":"175","author":"Rigamonti","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0280","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bmj.301.6763.1256","article-title":"Increased energy expenditure in Parkinson's disease","volume":"301","author":"Levi","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2016.05.018_bb0285","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yfrne.2009.10.008","article-title":"Ghrelin in the regulation of body weight and metabolism","volume":"31","author":"Casta\u00f1eda","year":"2010","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5717\/jenb.2015.15090806","article-title":"Effect of treadmill exercise on PI3K\/AKT\/mTOR, autophagy, and tau hyperphosphorylation in the cerebral cortex of NSE\/htau23 transgenic mice","volume":"19","author":"Kang","year":"2015","journal-title":"J Exerc Nutr Biochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0295","first-page":"1646","article-title":"mTor mediates tau localization and secretion: Implication for Alzheimer's disease","volume":"2015","author":"Tang","year":"1853","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2016.05.018_bb0300","first-page":"1","article-title":"Dysfunction of the mTOR pathway is a riskfactor for Alzheimer's disease","volume":"8","author":"Yates","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.metabol.2016.05.018_bb0305","doi-asserted-by":"crossref","first-page":"161020","DOI":"10.1155\/2015\/161020","article-title":"PI3K\/AKT\/mTOR\/p70S6K pathway is involved in A\u03b225-35-induced autophagy","volume":"2015","author":"Fan","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2016.05.018_bb0310","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0315","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/elps.201400450","article-title":"Metabolomics reveals significant impairments in the immune system of the app\/ps1 transgenic mice of alzheimer's disease","volume":"36","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2014.01.021","article-title":"Circulating levels of adipokines in Parkinson's disease","volume":"339","author":"Rocha","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br Med Bull"},{"key":"10.1016\/j.metabol.2016.05.018_bb0335","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.metabol.2016.05.018_bb0345","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","article-title":"Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta","volume":"25","author":"Baquet","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0350","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00415-009-0062-8","article-title":"Weight loss in neurodegenerative disorders","volume":"255","author":"Aziz","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0355","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","article-title":"The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life","volume":"259","author":"Antonini","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jns.2014.10.032","article-title":"Influencing effect of non-motor symptom clusters on quality of life in Parkinson's disease","volume":"347","author":"Kim","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0365","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2013.12.021","article-title":"Dietary restriction in cerebral bioenergetics and redox state","volume":"2","author":"Amigo","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0370","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.05.018_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2013.11.001","article-title":"Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice","volume":"251","author":"Wang","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00313602","article-title":"Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease","volume":"87","author":"Moroo","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0385","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0390","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0006-8993(00)02573-7","article-title":"Glucose-regulated dopamine release from substantia nigra neurons","volume":"874","author":"Levin","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0395","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","article-title":"Shared dysregulated pathways lead to Parkinson's disease and diabetes","volume":"19","author":"Santiago","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0400","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jnnp.2009.175752","article-title":"Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease","volume":"81","author":"Godau","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.metabol.2016.05.018_bb0405","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jocn.2009.08.013","article-title":"Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease","volume":"17","author":"Mashayekhi","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0410","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00415-013-6851-0","article-title":"Insulin-like growth factor-1 and progression of motor symptoms in early, drug-na\u00efve Parkinson's disease","volume":"260","author":"Picillo","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0415","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1142179","article-title":"Brain IRS2 signaling coordinates life span and nutrient homeostasis","volume":"317","author":"Taguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.05.018_bb0420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00109-003-0499-7","article-title":"Role of insulin-like growth factor I signaling in neurodegenerative diseases","volume":"82","author":"Trejo","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0425","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(01)02344-8","article-title":"Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: Possible implications for Parkinson's disease","volume":"316","author":"Offen","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.metabol.2016.05.018_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tox.2010.01.001","article-title":"Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta","volume":"271","author":"Sun","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0435","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/exnr.1996.0115","article-title":"Growth factors rescue embryonic dopamine neurons from programmed cell death","volume":"140","author":"Zawada","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0445","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/01.wnr.0000127461.15985.07","article-title":"N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats","volume":"15","author":"Krishnamurthi","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.metabol.2016.05.018_bb0450","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/dneu.20609","article-title":"PI3 kinase\/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease","volume":"68","author":"Quesada","year":"2008","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/00207459309003322","article-title":"The relationship between diabetes mellitus and Parkinson's disease","volume":"69","author":"Sandyk","year":"1993","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0460","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(96)00727-5","article-title":"Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: A molecular study","volume":"736","author":"Figlewicz","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0465","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(02)04087-8","article-title":"Expression of receptors for insulin and leptin in the ventral tegmental area\/substantia nigra (VTA\/SN) of the rat","volume":"964","author":"Figlewicz","year":"2003","journal-title":"Brain Res"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2016.05.018_bb0470","first-page":"III30","article-title":"Environmental, life-style, and physical precursors of clinical Parkinson's disease: Recent findings from the Honolulu\u2013Asia aging study","volume":"250","author":"Abbott","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0475","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0480","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.1165","article-title":"Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss","volume":"16","author":"Evidente","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.metabol.2016.05.018_bb0485","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2006.08.053","article-title":"Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells","volume":"407","author":"Lu","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.metabol.2016.05.018_bb0490","doi-asserted-by":"crossref","first-page":"34479","DOI":"10.1074\/jbc.M705426200","article-title":"Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling","volume":"282","author":"Weng","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0495","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.1992.tb08880.x","article-title":"Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system","volume":"59","author":"Spina","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0500","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9109-y","article-title":"Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells","volume":"17","author":"Ho","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0505","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1523\/JNEUROSCI.4269-04.2005","article-title":"Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease","volume":"25","author":"Andrews","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0510","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0515","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","article-title":"Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation","volume":"15","author":"Moon","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2042018813479645","article-title":"Ghrelin is neuroprotective in Parkinson's disease: Molecular mechanisms of metabolic neuroprotection","volume":"4","author":"Bayliss","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.05.018_bb0525","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: Future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.05.018_bb0530","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","article-title":"Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease","volume":"26","author":"Xu","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2016.05.018_bb0535","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1471-4159.2009.06463.x","article-title":"A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death","volume":"112","author":"Choi","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0540","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.metabol.2016.05.018_bb0545","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JPD-120155","article-title":"mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats","volume":"3","author":"Decressac","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0550","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.metabol.2016.05.018_bb0555","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","article-title":"Curcumin ameliorates the neurodegenerative pathology in A53T \u03b1-synuclein cell model of Parkinson's disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy","volume":"8","author":"Jiang","year":"2013","journal-title":"J NeuroImmune Pharmacol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0560","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12035-014-8744-3","article-title":"Aberrant autophagy and parkinsonism: Does correction rescue from disease progression?","volume":"51","author":"Mishra","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0565","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.169","article-title":"Alpha-synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons","volume":"6","author":"Koch","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0570","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.05.018_bb0575","doi-asserted-by":"crossref","first-page":"16503","DOI":"10.1523\/JNEUROSCI.0209-12.2012","article-title":"Development and characterization of a new Parkinson's disease model resulting from impaired autophagy","volume":"32","author":"Ahmed","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0580","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.autrev.2014.01.012","article-title":"Revised diagnostic criteria of multiple sclerosis","volume":"13","author":"Milo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.metabol.2016.05.018_bb0585","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: Geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.metabol.2016.05.018_bb0590","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/01.wnl.0000275229.13012.32","article-title":"Pathogenesis of axonal and neuronal damage in multiple sclerosis","volume":"68","author":"Dutta","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0595","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: An immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0600","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.wco.0000318863.65635.9a","article-title":"Cortical pathology in multiple sclerosis","volume":"21","author":"Stadelmann","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0605","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0610","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/brain\/120.5.865","article-title":"Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives","volume":"120","author":"Hohlfeld","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2016.05.018_bb0615","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)64677-9","article-title":"Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions","volume":"158","author":"Liu","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0620","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxicoligodendroglial death anddemyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0625","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.23-09-03588.2003","article-title":"Functional hemichannelsin astrocytes: A novel mechanism of glutamate release","volume":"23","author":"Ye","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0630","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nature04474","article-title":"NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia","volume":"439","author":"Micu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.05.018_bb0635","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1523\/JNEUROSCI.23-21-07922.2003","article-title":"Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS","volume":"23","author":"Babcock","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0640","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"73","author":"Munger","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0645","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body index before age 20 is associated with increased risk for multiple sclerosis men and women","volume":"18","author":"Hedstr\u00f6m","year":"2012","journal-title":"Mult Scler J"},{"key":"10.1016\/j.metabol.2016.05.018_bb0650","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.0b013e31828154f3","article-title":"Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome","volume":"80","author":"Langer-gould","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0655","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.4049\/jimmunol.166.10.5909","article-title":"Requirement for leptin in the induction and progression of autoimmune encephalomyelitis","volume":"166","author":"Matarese","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0660","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI200316721","article-title":"Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses","volume":"111","author":"Sanna","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0665","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI26523","article-title":"Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis","volume":"116","author":"De Rosa","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0670","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.4049\/jimmunol.1001674","article-title":"Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient\/energy-sensing mammalian target of rapamycinsignaling pathway","volume":"185","author":"Galgani","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0675","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2014.02.003","article-title":"Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling","volume":"40","author":"Ouyang","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.metabol.2016.05.018_bb0680","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneuroim.2007.08.008","article-title":"The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing\u2013remitting multiple sclerosis","volume":"192","author":"Frisullo","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0685","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0690","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0165-5728(03)00154-1","article-title":"Leptin as marker of multiple sclerosis activity in patients treated with interferon-\u03b2","volume":"139","author":"Batocchi","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0695","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1073\/pnas.0408995102","article-title":"Leptin increase in multiple sclerosis associates with reduced number of CD4+ CD25+ regulatory T cells","volume":"102","author":"Matarese","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.05.018_bb0700","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1172\/JCI69346","article-title":"Leptin and the brain: Then and now","volume":"123","author":"Schwartz","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.05.018_bb0705","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1210\/endo.140.6.6774","article-title":"Regulation of neuronal and glial proteins by leptin: Implications for brain development","volume":"140","author":"Ahima","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0710","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1189\/jlb.0208133","article-title":"Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis","volume":"8","author":"Piccio","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0715","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF03167069","article-title":"Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction","volume":"60","author":"Esquifino","year":"2004","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0720","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-4-6","article-title":"Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction","volume":"4","author":"Esquifino","year":"2007","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.metabol.2016.05.018_bb0725","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tips.2009.11.004","article-title":"Calorie restriction and cancer prevention: Metabolic and molecular mechanisms","volume":"31","author":"Longo","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0730","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0803362","article-title":"Suppression of experimental autoimmune encephalomyelitis by ghrelin","volume":"183","author":"Theil","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0735","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11011-015-9665-1","article-title":"Hyperinsulinemia in newly diagnosed patients with multiple sclerosis","volume":"30","author":"Penesova","year":"2015","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0740","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0074-7742(07)79009-8","article-title":"The insulin-like growth factor system in multiple sclerosis","volume":"79","author":"Chesik","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0745","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.15252\/emmm.201303376","article-title":"Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease","volume":"6","author":"Bilbao","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0750","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2015.03.082","article-title":"Insulin-like growth factor-binding protein 7 is up-regulated during EAE and inhibits the differentiation of oligodendrocyte precursor cells","volume":"460","author":"Tan","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.05.018_bb0755","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1191\/1352458505ms1123oa","article-title":"Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis","volume":"11","author":"Wilczak","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.metabol.2016.05.018_bb0760","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0765","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2010.01.001","article-title":"Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation","volume":"220","author":"Esposito","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0770","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2016.05.018_bb0775","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0780","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.4049\/jimmunol.177.8.5163","article-title":"Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death","volume":"177","author":"Li","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0785","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20061303","article-title":"A critical role for the autophagy gene Atg5 in T cell survival and proliferation","volume":"204","author":"Pua","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0790","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4161\/auto.3908","article-title":"Maintaining T lymphocyte homeostasis: Another duty of autophagy","volume":"3","author":"Pua","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.metabol.2016.05.018_bb0795","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.05.018_bb0800","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0026-895X(25)09102-3","article-title":"Delayed increase of Ca2+ influx elicited by glutamate: Role in neuronal death","volume":"36","author":"Manev","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0805","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.metabol.2016.05.018_bb0810","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.metabol.2016.05.018_bb0815","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: Clinical consequences and therapeutic implications","volume":"18","author":"Aziz","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0820","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.171.4.393c","article-title":"Sleep disturbance and Huntingdon's disease","volume":"17","author":"Taylor","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.metabol.2016.05.018_bb0825","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.05.018_bb0830","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0835","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0840","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinicacid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2016.05.018_bb0845","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(96)00223-0","article-title":"Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatalinjections of quinolinate or 3-nitropropionic acid","volume":"76","author":"Nakao","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.metabol.2016.05.018_bb0850","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.05.018_bb0855","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","article-title":"Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models","volume":"15","author":"Portera-Cailliau","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0860","first-page":"C755","article-title":"Mechanisms by which mitochondria transport calcium","volume":"258","author":"Gunter","year":"1990","journal-title":"Am J Phys"},{"key":"10.1016\/j.metabol.2016.05.018_bb0865","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.05.018_bb0870","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","article-title":"Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation","volume":"15","author":"Reynolds","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0875","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.1992.00530280029014","article-title":"Weight loss in Huntington's disease","volume":"4","author":"Kremer","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0880","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0885","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ajcn\/81.6.1335","article-title":"Energy balance in early-stage Huntington disease","volume":"81","author":"Gaba","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2016.05.018_bb0890","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0895","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington's disease","volume":"47","author":"Pratley","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0900","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0597-575","article-title":"Human leptin levels are pulsatile and inversely related to pituitary\u2013adrenal function","volume":"3","author":"Licinio","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb0905","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djouss\u00e9","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0910","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington's disease","volume":"24","author":"Peters\u00e9n","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0915","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1530\/eje.0.1500731","article-title":"Orexin a suppresses in vivo GH secretion","volume":"150","author":"Seoane","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0920","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","article-title":"Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease","volume":"17","author":"Aziz","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0925","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11033-012-1993-1","article-title":"Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis","volume":"40","author":"Zhang","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.metabol.2016.05.018_bb0930","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2016.05.018_bb0935","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0940","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0945","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0950","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2016.01.009","article-title":"Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin","author":"Naia","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.metabol.2016.05.018_bb0960","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.expneurol.2011.06.016","article-title":"IGF-1 protects against diabetic features in an in vivo model of Huntington's disease","volume":"231","author":"Duarte","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0965","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.metabol.2016.05.018_bb0970","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","article-title":"Huntington French speaking group. High insulinlike growth factor I is associated with cognitive decline in Huntington disease","volume":"75","author":"Saleh","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2016.05.018_bb0975","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","article-title":"Akt is altered in an animal model of Huntington's disease and in patients","volume":"21","author":"Colin","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.metabol.2016.05.018_bb0980","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.metabol.2016.05.018_bb0985","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.05.018_bb0990","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.metabol.2016.05.018_bb0995","doi-asserted-by":"crossref","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","article-title":"Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease","volume":"7","author":"Pryor","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.metabol.2016.05.018_bb1000","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.metabol.2016.05.018_bb1005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2016.05.018_bb1010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway","volume":"172","author":"Yamamoto","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2016.05.018_bb1015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation an the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.metabol.2016.05.018_bb1020","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2016.05.018_bb1025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.05.018_bb1030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1173635","article-title":"Caloric restriction delays disease onset and mortality in rhesus monkeys","volume":"325","author":"Colman","year":"2009","journal-title":"Science"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:58Z","timestamp":1758427978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516300397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":206,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0026049516300397"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.05.018","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of metabolism in neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}